Back

Discussion.

30 August 2020 (19:20 - 19:30)
Organised by:
Congress Presentation Part of: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides Lipid-Lowering Agents Open Access ESC Congress 2020

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor P. Libby (Boston, US)
Video
Presentation thumbnail
The residual risk challenge in CVD: How important are triglycerides?
Professor U. Landmesser (Berlin, DE)
Video
Presentation thumbnail
Non-LDL in CV risk management & guidelines: What are the opportunities?
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Lessons from REDUCE-IT: How will the results impact practice?
Professor D. Bhatt (New York City, US)
Video

Access the full session

Session thumbnail
Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
Video

The Event

Event poster

ESC Congress 2020

30 August 2020 19:20 CET
You may be interested in
thumbnail
Congress Presentation
Lipid and secondary prevention 'up to date'
28 August 2023
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
Icosapent ethyl in clinical practice: the Spanish experience
29 August 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources